NMT Pharma

NanoMaterials Technology focuses on drugs delivered by the solid oral and pulmonary inhalation routes

Solid oral drugs

• A reduction in particle size of poorly soluble solid oral drug will result in a substantial increase in the dissolution rate

Pulmonary inhalation drugs

• Good dispersion of inhalable drugs within the lungs depends on particle size, morphology and surface properties of the drug particles. The HGCP technology platform allows good control over these properties to design inhalable drugs with good dispersion.

The videos below show the higher fine particle fraction achievable with pulmonary inhalation drugs (in this case, a common asthma drug salbutamol sulphate) on re-designing the drug particles

Original	HGCP processed

Download Video Clips

• Commercial Salbutamol Sulphate
• Nano Salbutamol Sulphate